Ischemic stroke reperfusion injury is driven by oxidative stress and neuroinflammation, but current neuroprotective strategies suffer from poor targeting, limited functionality, and low blood‑‐brain barrier (BBB) penetration. Herein, a multifunctional nanoplatform (RM@HPAN) is constructed: a hollow mesoporous Prussian blue core with multi‑enzyme mimetic activity, loaded with L‑arginine and butylphthalide, cloaked with red blood cell membrane for immune evasion, and modified with RVG‑29 for brain targeting. RM@HPAN exhibits ideal nanosize, pH‑responsive release, and robust ROS scavenging. It crosses a BBB model in vitro and boosts neuronal viability under oxygen‑‐glucose deprivation/reoxygenation. In a mouse middle cerebral artery occlusion model, RM@HPAN targets ischemic regions, reduces infarct volume from 29.4% to 3.8%, improves neurological scores, and rebalances inflammatory cytokines (TNF‑α, IL‑6, IL‑10, TGF‑β1). Transcriptomic and proteomic analyses reveal that RM@HPAN suppresses cytokine‑cytokine receptor interaction and TNF signaling while activating Rap1/PI3K/Akt and Nrf2/HO‑1 pathways, thereby inhibiting apoptosis and oxidative stress. Biosafety assessments confirm good biocompatibility. Thus, RM@HPAN offers a promising translatable strategy for ischemic stroke.
Ischemic stroke (IS) is one of the primary causes of global mortality and permanent neurological disability, and its clinical treatment is severely constrained by the intricate ischemic pathological cascade and the impermeable blood‐brain barrier (BBB). Cerebral ischemia and reperfusion trigger a series of pathologic...
Yan-Han Huang, Xuan Hou, Haiping Zhao et al.· Responsive Materials· 0 citations
Ischemic stroke (IS) is severely aggravated by oxidative stress and neuroinflammation, while the blood-brain barrier (BBB) poses a major obstacle to effective therapy. Herein, we developed a brain-targeted nanozyme system (TLNP@Pt/Fe3O4) by encapsulating Pt/Fe3O4 nanozymes into T7 peptide-modified lipid nanoparticles....
Bo-Yang Wei, Yu Wu, Jia-Ming Zhou et al.· ACS Applied Materials and In...· 0 citations
There is limited direct evidence of fully integrated nanozyme-hydrogel platforms specifically for stroke; the field largely relies on the intersection of advanced stroke nanozymes and responsive hydrogels.
Sen Yan, Xiao-Hong Wang, Cai Li et al.· Frontiers in Neurology· 0 citations
A repair system based on magnetothermal controlled release of hydrogen selenide achieved nerve regeneration and functional recovery comparable to autologous grafts in rats, and offers a promising approach for neural repair.
Xin-Yue Liang, Jun-Wei Su, Jun-Wei Yang et al.· Advanced Functional Material...· 0 citations
A RVG‐modified liposomal nanoplatform for targeted delivery of mollugin (Mol@Lip‐RVG) as a novel therapeutic strategy for SCI resulted in enhanced neuro‐preservation and substantial improvement in motor function recovery, achieved through dual modulation of microglial reprogramming and attenuation of oxidative stress.
Quan Zhou, I. Shaikh, Jian-Feng Wang et al.· Advanced Healthcare Material...· 0 citations